FDA Okays First Generics for MS Drug Fingolimod (Gilenya) FDA Okays First Generics for MS Drug Fingolimod (Gilenya)

The FDA granted three companies approval to market generic copies of fingolimod (Gilenya), the first oral disease-modifying multiple sclerosis therapy approved in 2010.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news